Australia's Atomo Diagnostics surges on govt support for HIV self-tests

Atomo Diagnostics

16/05/2024 04:38

** Shares of medical devices maker Atomo Diagnostics
 AT1.AX  rise as much as ~63% to A$0.044, their highest since
March 6
    ** Australian government in its federal budget announced
commitments to fund expansion of HIV self-testing
    ** Co says it supplies the only HIV self-test included on
the Australian Register of Therapeutic Goods
    ** Adds it sees a significant portion of funding for HIV
self-test programs to be used for procurement of Atomo HIV tests
    ** About 13.5 mln shares change hand compared to 30-day
average of 655,203 shares
    ** Stock up 22.7% YTD as of last close

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))